Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06561893Not ApplicableCompleted

Effect of L. Plantarum Probiotic Supplementation on Broccoli Sulforaphane Bioavailability: Randomised Double-blind Placebo-controlled Crossover Study

Role: collaborator

NCT02800408Not ApplicableCompleted

Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans

Role: collaborator

NCT02979496Not ApplicableCompleted

Citrus Beverages and Gastrointestinal Function

Role: collaborator

NCT02575131Phase 2Completed

Breakfast Test Products and Acute Satiety Scores

Role: collaborator

NCT02847312Not ApplicableUnknown

Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure

Role: collaborator

All 5 trials loaded